Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 27, 2021 at 09:11 am
Share
Beihai Gofar Chuanshan Biological Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 304.63 million compared to CNY 181.34 million a year ago. Revenue was CNY 304.63 million compared to CNY 181.34 million a year ago. Net income was CNY 7.8 million compared to net loss of CNY 5.3 million a year ago. Basic earnings per share from continuing operations was CNY 0.02 compared to basic loss per share from continuing operations of CNY 0.01 a year ago. Diluted earnings per share from continuing operations was CNY 0.02 compared to diluted loss per share from continuing operations of CNY 0.01 a year ago.
Beihai Gofar Chuanshan Biological Co Ltd, formerly Beihai Gofar Marine Biological Industry Co Ltd, is a China-based company mainly engaged in the production and sales of pharmaceutical products and pesticide products. The Company is mainly engaged in the Pharmaceutical Distribution segment, the Pharmaceutical Manufacturing segment, the Deoxyribonucleic Acid Identification and Service segment, and the Other segment. The Company is mainly engaged in pharmaceutical manufacturing and pharmaceutical distribution industries, molecular medical imaging centers, tumor radiotherapy centers, and tumor telemedicine technical services, molecular diagnostics and judicial identification technical services. The Company mainly sells its products in the domestic market.